What is eLIVE?

eLIVE is a Laboratory Developed Test (LDT) that uses cytokine profiling from a live tumor biopsy to predict a patient's likelihood of response to an immune checkpoint inhibitor (ICI).

How it works

A licensed clinician submits an order for eLIVE. Elephas Laboratories will then ship a proprietary collection kit to the facility where the biopsy will be performed.

Collect

Collect biopsy. Follow proprietary collection kit protocol to maintain live tumor microenvironment.

Ship

Send live biopsy to Elephas Laboratories where the sample's response is assessed following exposure to treatment.

Result

Receive tumor response profile and pathologist interpretation within 14 days .

Ready to order?

eLIVE is currently available to licensed healthcare providers only.
Patients seeking eLIVE should contact their clinicians.

Order online

Order via our secure, HIPAA-compliant order management system.

Access Ordering Portal

Email or eFax

Download the order form. Complete and return via email or fax to (855) 350-1433.

Download Order Form

Contact eLIVE support with questions.

Elephas Laboratories CLIA #52D2333937

Laboratory Opening Hours: Monday to Friday: 8:00 a.m. to 5:00 p.m. CT.

Phone: (608) 622-7954 | Email: elive@elephaslabs.com

A dedicated support team is available Monday to Friday from 8:00 a.m. to 6:00 p.m. CT.

References: 1. T.S. Ramasubramanian, et al. Pichet Adstamongkonkul, Christina M. Scribano et al. A live tumor fragment platform to assess immunotherapy response in core needle biopsies while addressing challenges of tumor heterogeneity bioRxiv 2025.07.18.663728; doi: https://doi.org/10.1101/2025.07.18.663728 2. Voabil P, de Bruijn M, Roelofsen LM, et al. An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer. Nature medicine. 2021;27(7):1250-1261. doi:10.1038/s41591-021-01398-3

Evaluate IO therapy response before treatment begins.